Story · Medicine & Biotech

Impact of Inclisiran on Apolipoprotein B in Patients With Hyperlipidemia: A Systematic Review and Meta-Analysis

1 outlet · first reported by Cureus 2h ago

Coverage, in order

  1. 2h ago
    Cureus indie study meta-analysis
    Impact of Inclisiran on Apolipoprotein B in Patients With Hyperlipidemia: A Systematic Review and Meta-Analysis

    Statins are recommended as first-line therapy for managing hyperlipidemia. However, a significant number of patients fail to achieve optimal lipid control with statins, leading to the development of newer pharmacotherapies. Inclisiran, administered twice yearly, has shown efficacy in lowering…

Alivewire groups outlets reporting the same story. Each headline links to the outlet that wrote it; nothing is republished here.